site logo

Wall Street paints rosy 2021 for medtech as electives snap back

After dealing with economic challenges throughout 2020, analysts said procedure-dependent companies like Medtronic, Abbott and Zimmer Biomet may outperform this year as procedure volumes return.

Getty Images